Skip to main content
logo
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
86.00
+1.44 (1.70%)
At close: Apr 2, 2026, 4:00 PM EDT
84.34
-1.66 (-1.93%)
After-hours: Apr 2, 2026, 5:09 PM EDT

Dianthus Therapeutics Revenue

In the year 2025, Dianthus Therapeutics had annual revenue of $2.04M, down -67.35%. Dianthus Therapeutics had revenue of $284.00K in the quarter ending December 31, 2025, a decrease of -78.58%.

Revenue (ttm)
$2.04M
Revenue Growth
-67.35%
P/S Ratio
2,236.26
Revenue / Employee
$22,130
Employees
92
Market Cap
4.55B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.04M-4.20M-67.35%
Dec 31, 20246.24M3.41M120.63%
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.00B
Corcept Therapeutics761.41M
Amicus Therapeutics634.21M
TG Therapeutics616.29M
Ligand Pharmaceuticals268.09M
Crinetics Pharmaceuticals7.70M
Xenon Pharmaceuticals7.50M
CRISPR Therapeutics AG3.51M
Revenue Rankings

DNTH News

More News